Table 4.
Comparison of seropositive seroconversion rates (%) and antibody GMC (IU/mL) of participants in different groups after rabies vaccination.
| Blood Collection Time | FAS | PPS | ||||
|---|---|---|---|---|---|---|
| Zagreb group (N=599) |
Essen group (N=600) |
P value | Zagreb group (N=519) |
Essen group (N=496) |
P value | |
| Pre-Vaccination (D0) | ||||||
| Positivity Rate | 59 (9.85%) | 61 (10.17%) | 0.855 | / | / | / |
| GMC | 0.13 (0.12, 0.14) | 0.13 (0.12, 0.14) | 0.823 | 0.10 (0.10, 0.10) | 0.10 (0.10, 0.11) | 1.000 |
| 14 days after the first dose (D14) | ||||||
| Seropositive seroconversion rate | 592 (98.83%) | 582 (97.00%) | 0.027 | 519 (100%) | 496 (100%) | 1.000 |
| GMC | 63.75 (58.49, 69.48) | 60.91 (54.69, 67.84) | 0.517 | 65.44 (61.33, 69.81) | 70.87 (66.33, 75.72) | 0.091* |
| 14 days after full vaccination (D35/D42) | ||||||
| Seropositive seroconversion rate | 592 (100%) | 577 (100%) | 1.000 | 519 (100%) | 496 (100%) | 1.000 |
| GMC | 37.04 (34.08, 40.26) | 32.33 (29.24, 35.75) | 0.041 | 36.83 (34.50, 39.31) | 35.80 (33.49, 38.26) | 0.551 |
*Covariance analysis result.